Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maitri Enterprises Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Maitri Enterprises's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Maitri Enterprises's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitri Enterprises Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitri Enterprises's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Maitri Enterprises's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitri Enterprises (BOM:513430) has a Buyback Yield % of 0.00 as of Aug. 14, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Maitri Enterprises and its competitors. According to the industry distribution chart, Maitri Enterprises ranks #999999 out of 265 companies in the Healthcare Providers & Services industry.
Is Maitri Enterprises' Buyback Yield % too high?
Maitri Enterprises' current Buyback Yield % is 0.00. Based on the distribution chart, Maitri Enterprises ranks #999999 out of 265 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Maitri Enterprises has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maitri Enterprises' Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Maitri Enterprises ranks #999999 out of 265 companies for Buyback Yield %. This places Maitri Enterprises in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Maitri Enterprises and its competitors. Maitri Enterprises's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitri Enterprises stock overvalued right now?
Based on GuruFocus' analysis, Maitri Enterprises (BOM:513430) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹53.01, compared to a current price of ₹42.88 — trading 19.1% below its estimated fair value. The current Buyback Yield % is 0.00. Maitri Enterprises' overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Maitri Enterprises (BOM:513430), the current Buyback Yield % is 0.00 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maitri Enterprises (BOM:513430) Overvalued in 2026?
Based on GuruFocus' analysis, Maitri Enterprises stock appears to be undervalued.
The current stock price of ₹42.88 is trading 19.1% below its estimated GF Value™ of ₹53.01.
GuruFocus considers Maitri Enterprises to be Modestly Undervalued.
Key valuation signals for BOM:513430:
Buyback Yield %: 0.00
GF Value™: ₹53.01 vs. price of ₹42.88 (19.1% below fair value)
No single metric tells the full story. See the BOM:513430 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maitri Enterprises Ltd is engaged in the trading of pharmaceutical and medical goods in India. It is also involved in the sale of services by way of a works contract. The company's operating and reporting segments are: Pharmaceutical Goods, and Infrastructure and Real Estate. The majority of its revenue is generated from the provision of work contract services.
76GF Score
Get the complete analysis for BOM:513430
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:513430 has been successfully added to your 
